Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q3 2026 Earnings

6AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.46

-0.34

-0.23

-0.11

Details

Expected EPS

-0.199533

Actual EPS

-0.11

Surprise EPS

0.09

Surprise Percent

+44.87%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.11 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.